Research Repository

Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1

Vassilaros, S, Tsibanis, A, Tsikkinis, A, Pietersz, GA, McKenzie, IFC and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2013) Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1. Immunotherapy, 5 (11). 1177 - 1182. ISSN 1750-743X

[img] Text
15yrfollowup%20copy[1].pdf - Submitted Version
Restricted to Repository staff only

Download (157kB)
Item Type: Article
Uncontrolled Keywords: Mucin 1; glycoproteins; vaccines; vaccination
Subjects: FOR Classification > 1107 Immunology
Faculty/School/Research Centre/Department > Centre for Chronic Disease Prevention and Management
Faculty/School/Research Centre/Department > Other
Depositing User: Symplectic Elements
Date Deposited: 02 Aug 2017 23:50
Last Modified: 21 Aug 2017 04:26
URI: http://vuir.vu.edu.au/id/eprint/33967
DOI: https://doi.org/10.2217/imt.13.126
ePrint Statistics: View download statistics for this item
Citations in Scopus: 41 - View on Scopus

Repository staff only

View Item View Item

Search Google Scholar